A Study of Lebrikizumab (MILR1444A) in Adult Patients With Asthma Who Are Inadequately Controlled on Inhaled Corticosteroids

NCT00930163 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

218

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: lebrikizumab (MILR1444A)
DRUG: placebo

Sponsor

Genentech, Inc.